Fourth, using the lower limit of normal in cerebral blood flow reduction, 90% ME/CFS (95% CI 87-92%) patients showed a more than 13% reduction. The findings confirm and extend previous reports of a high prevalence of orthostatic intolerance in the ME/CFS population. Our results show that 98% of delayed orthostatic hypotension patients and 100% of POTS patients had a more than 13% cerebral blood flow reduction, inferring that in those with documented delayed orthostatic hypotension and POTS, clinically important reductions in cerebral blood flow could be assumed to be present. On the other hand, the largest group of ME/CFS patients were those with a normal heart rate/blood pressure response. Of this group, 82% had an abnormal cerebral blood flow decrease as defined by the lower limits of normal. These patients would have been misclassified as having normal hemodynamics using just heart rate and blood pressure changes during head-up tilt test. Our data suggest that for a more comprehensive categorization of the circulatory dysfunction in ME/CFS patients cerebral blood flow measurements should be included.